About Genomix Molecular Diagnostics Private Limited
Data last updated:
Genomix Molecular Diagnostics Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the biotechnology segment of the life sciences sector. It was incorporated on 03 January 2007 and has been in existence for over 19 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U85110TG2007PTC052224. Its GSTIN is 36AACCG7592C1ZK (Telangana).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5.2 Lakh. It is led by directors including Vijay Kumar Kanthamneni and Rathnagiri Polavarapu.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at D.No.5 – 36/207 Prashanth Nagar Kukatpally, Hyderabad, Telangana, India – 500072.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.21 Cr, a decline of 17% compared to the previous year. For the same year it recorded a net profit of ₹3.06 Lakh (net margin 1.4%) and EBITDA of ₹6.53 Lakh (EBITDA margin 2.9%). Revenue has declined at a compounded annual rate (CAGR) of 14% over three years and 6% over five years.
The company has about 7 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹29 Lakh on record. Court records list 1 case involving the company, including 1 filed by the company.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website genomixbiotech.com.
CIN History of Genomix Molecular Diagnostics Private Limited
Genomix Molecular Diagnostics has one previous CIN (Corporate Identification Number): U85110AP2007PTC052224. The current CIN is U85110TG2007PTC052224, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U85110TG2007PTC052224 | Current |
| U85110AP2007PTC052224 | Previous |
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressD.No.5 – 36/207 Prashanth Nagar Kukatpally, Hyderabad, Telangana, India – 500072
- IndustryLife Sciences, Biotechnology
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Genomix Molecular Diagnostics Private Limited
The main business activity of Genomix Molecular Diagnostics is professional, scientific and technical. In detail, this covers scientific research and development.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Genomix Molecular Diagnostics Private Limited FY 2024 filings available
Genomix Molecular Diagnostics Private Limited reported revenue of ₹2.21 Cr (down 17% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Genomix Molecular Diagnostics Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 6% over five years, including a 17% fall in the latest year. EBITDA rose 8% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Genomix Molecular Diagnostics Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹6.53 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹3.06 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Genomix Molecular Diagnostics Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.9% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 1.4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Genomix Molecular Diagnostics are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Genomix Molecular Diagnostics Private Limited
Genomix Molecular Diagnostics has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vijay Kumar Kanthamneni | Director | 03 Jan 2007 | 19 Years 9 Months | Current |
| Rathnagiri Polavarapu | Director | 03 Jan 2007 | 19 Years 9 Months | Current |
| Bilhan Kavikishore Polavarapu Also directs: Genomix Carl Private Limited | Director | 18 Aug 2021 | 5 Years 2 Months | Current |
Peer Comparison of Genomix Molecular Diagnostics Private Limited
Genomix Molecular Diagnostics Private Limited is compared with the companies closest to it by revenue in the Biotechnology industry (Biotechnology). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Om Sai Clinical Research Private Limited | ₹2.25 Cr (FY 2025) | •••• | •••• | 131.0% | •••• | Sangli, Maharashtra, India |
| Immuneel Therapeutics Private Limited | ₹2.25 Cr (FY 2024) | •••• | •••• | -47.0% | •••• | Bengaluru, Karnataka, India |
| CSK Bio Consulting Private Limited | ₹2.24 Cr (FY 2025) | •••• | •••• | 21.0% | •••• | New Delhi, Delhi, India |
| Clinfound Clinical Research Services Private Limited | ₹2.24 Cr (FY 2025) | •••• | •••• | -13.0% | •••• | Thodupuzha, Kerala, India |
| Zeinix Lifesciences Private Limited | ₹2.22 Cr (FY 2024) | •••• | •••• | 106.0% | •••• | Bangalore, Karnataka, India |
| Genomix Molecular Diagnostics Private Limited this company | ₹2.21 Cr (FY 2025) | •••• | •••• | -17.0% | •••• | Hyderabad, Telangana, India |
| Hisar Sperm Biotech Private Limited | ₹2.21 Cr (FY 2024) | •••• | •••• | 18.0% | •••• | Hisar, Haryana, India |
| Decode Dna Private Limited | ₹2.2 Cr (FY 2025) | •••• | •••• | 197.0% | •••• | Delhi, India |
| Sequence Biotech Private Limited | ₹2.19 Cr (FY 2025) | •••• | •••• | -27.0% | •••• | Nashik, Maharashtra, India |
| Pragathi Labs and Consultants Private Limited | ₹2.19 Cr (FY 2024) | •••• | •••• | 1.0% | •••• | Hyderabad, Telangana, India |
| Expo Biotech Limited | ₹2.18 Cr (FY 2024) | •••• | •••• | 735.0% | •••• | Bhubaneswar, Odisha, India |
Peers are the five companies nearest above and the five nearest below Genomix Molecular Diagnostics by revenue in the Biotechnology industry (Biotechnology), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Genomix Molecular Diagnostics Private Limited
Genomix Molecular Diagnostics Private Limited is audited by NAMBURU & ASSOCIATES for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| NAMBURU & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Genomix Molecular Diagnostics Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Genomix Molecular Diagnostics Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Sep 2009 | Department of Biotechnology | ₹29 Lakh | Open |
Total charge records: 1 View all charges
Legal Cases of Genomix Molecular Diagnostics Private Limited
Genomix Molecular Diagnostics Private Limited has 1 court case on record: 1 filed by Genomix Molecular Diagnostics. All case is disposed. Status as checked on 03 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 0 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court for State of Telangana | Writ petition | Filed by the company against an individual | Disposed |
Full case history
All 1 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Genomix Molecular Diagnostics Private Limited
Genomix Molecular Diagnostics Private Limited has a workforce of 7 employees as of Mar 31, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Genomix Molecular Diagnostics Private Limited
Genomix Molecular Diagnostics Private Limited has 7 board changes on record since 2007: 5 appointments and 2 cessations. The latest: Bilhan Kavikishore Polavarapu was appointed as Director on 18 Aug 2021.
Credit Ratings, Litigation & Regulatory Alerts for Genomix Molecular Diagnostics Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Genomix Molecular Diagnostics Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Genomix Molecular Diagnostics Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Genomix Molecular Diagnostics Private Limited
Genomix Molecular Diagnostics has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AACCG7592C1ZK | Telangana | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Genomix Molecular Diagnostics Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Genomix Molecular Diagnostics Private Limited
Genomix Molecular Diagnostics is an active private limited company based in Hyderabad, Telangana, India. The company works in biotechnology, within the life sciences industry. It was incorporated on 03 January 2007 (19+ years old) and is registered under CIN U85110TG2007PTC052224.
Genomix Molecular Diagnostics reported revenue of ₹2.21 Cr for FY 2025 (down 17% YoY).
Genomix Molecular Diagnostics has 3 current directors:
- Vijay Kumar Kanthamneni - Director
- Rathnagiri Polavarapu - Director
- Bilhan Kavikishore Polavarapu - Director
Genomix Molecular Diagnostics reported a net profit of ₹3.06 Lakh (net margin 1.4%) and EBITDA of ₹6.53 Lakh (EBITDA margin 2.9%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Genomix Molecular Diagnostics is -14% over three years and -6% over five years. In the latest year (FY 2025) revenue fell 17%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Genomix Molecular Diagnostics is 36AACCG7592C1ZK, registered in Telangana.
The CIN (Corporate Identification Number) of Genomix Molecular Diagnostics is U85110TG2007PTC052224. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Genomix Molecular Diagnostics has 1 court case on record: 1 filed by the company.
Genomix Molecular Diagnostics was incorporated on 03 January 2007, making it 19+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Genomix Molecular Diagnostics by revenue are Om Sai Clinical Research Private Limited, Immuneel Therapeutics Private Limited, CSK Bio Consulting Private Limited, Clinfound Clinical Research Services Private Limited, Zeinix Lifesciences Private Limited and 5 more, all in the Biotechnology industry (Biotechnology).
Bilhan Kavikishore Polavarapu was appointed as Director on 18 Aug 2021. Ojasvi Polavarapu ceased to be Director on 28 Feb 2019. Krishnakishore Kota ceased to be Director on 27 Feb 2019. Genomix Molecular Diagnostics has 7 board changes on record in total.